Vision Testing Systems in New Jersey

Talshir Medical Technologies Ltd., operating as RevitalVision, develops FDA-cleared perceptual learning and vision training software designed to improve the brain's visual processing. RevitalVision is indicated for amblyopia (lazy eye) in patients aged 9 and older, making it the only FDA-cleared product with efficacy claims for adult amblyopia as a standalone therapy without upper age limits. The platform uses proprietary perceptual learning technology supported by randomized controlled, double-blind clinical studies published in peer-reviewed journals. Beyond amblyopia treatment, RevitalVision addresses post-cataract surgery vision recovery, low myopia, presbyopia (read without glasses), sports vision enhancement, post-LASIK vision improvement, and low vision from eye diseases. Clinical evidence demonstrates an average 2.5-line improvement on ETDRS visual acuity charts, 100% improvement in contrast sensitivity (FACT sine wave), and enhanced stereo and binocular functions. The company operates a B2B2C model where ophthalmologists, optometrists, orthoptists, and optometry doctors subscribe to monthly or annual plans, then offer therapy programs to patients. Training sessions are administered at-home (3–4 per week) with periodic in-clinic assessments. The American Medical Association has assigned two unique CPT codes (0687T and 0688T) for RevitalVision amblyopia therapy, effective January 2022, supporting insurance coverage pathways. More than 30 clinical studies across the USA, Europe, and Asia support efficacy, with 12 published in peer-reviewed journals. The company operates globally with approximately 400 clinics and 15,000 treated patients reported.

Bausch + Lomb is a global eye health company founded in 1853, headquartered in Rochester, New York, with over 12,000 employees worldwide. The company is a leader in vision care, ophthalmic pharmaceuticals, and surgical products. Bausch + Lomb offers a comprehensive portfolio including contact lenses (daily disposables and multifocal options), lens care solutions, ophthalmic pharmaceuticals, ophthalmic surgical devices, and surgical laser systems. The company serves millions of healthcare professionals and consumers globally, with a commitment to innovation in vision correction, surgical advancements, and eye health solutions. Bausch + Lomb maintains a strong track record in pharmaceutical manufacturing, optical coatings, and lens materials development.

Canfield Scientific is a global leader in medical imaging systems, software, and clinical research services founded in 1986. The company specializes in advanced 3D and 2D imaging solutions for dermatology, plastic surgery, and aesthetic medicine practices. Core offerings include the VISIA complexion analysis system (skin assessment and hyperpigmentation detection), VECTRA whole-body 3D imaging platforms (body mapping and surgical planning), VEOS portable dermoscopy systems, D2 dermoscopy software, and IntelliStudio software suites for clinical documentation and patient communication. Canfield serves pharmaceutical, biotechnology, cosmetic, and healthcare sectors globally through a network of partners in over 50 countries, providing integrated imaging documentation, clinical analysis services, and AI-assisted diagnostic tools to support treatment planning and patient outcomes.

NEXTMARVEL INC, operating under the brand Zeelool, is an online eyewear retailer specializing in prescription glasses, sunglasses, and optical frames for men, women, and children. The company offers a comprehensive range of eyeglass frames in various materials (acetate, plastic, metal, titanium, TR90) and frame styles (aviator, cat-eye, round, oval, browline, geometric, rectangle, butterfly, square). Zeelool provides prescription lens customization including single-vision, progressive, photochromic, blue-light blocking, driving, polarized, color-tinted, and Transitions® lenses. The company serves the direct-to-consumer eyewear market with offerings organized by face shape, lifestyle (professional, daily essentials, weekend wear, vacation, sporty, show-stopper), and specific vision needs. Zeelool maintains a 30-day exchange and return policy with a 365-day warranty. The company operates regional websites for the US, UK, Germany, France, and Canada, and offers multiple customer engagement programs including influencer partnerships, affiliate programs, educational discounts, and ambassador initiatives. While not a B2B medical device manufacturer, Zeelool functions as a consumer eyewear distributor with online customization capabilities and direct customer fulfillment. No FDA 510(k) or medical device certifications are claimed on the website.

Olleyes, Inc. is a medical device company specializing in portable, virtual reality-based diagnostic platforms for eye care practices. Founded by Dr. Alberto Gonzalez-Garcia, Olleyes develops FDA-registered Class I medical devices that enable rapid, portable visual field testing and comprehensive ophthalmic assessments. The flagship VisuALL platform features ultra-high-definition (4K) resolution, a proprietary eye-tracking algorithm (Dynamic Matrix) that minimizes fixation loss, and support for pediatric-optimized testing protocols. The system offers multiple diagnostic tests including visual field (24-2, 10-2, 30-2 protocols), visual acuity, color vision, contrast sensitivity, pupillometry, and extraocular motility assessment. Olleyes provides three main product variants: VisuALL S (basic office use), VisuALL ETS (comprehensive with eye tracking and automated examination suite), and VisuALL C (screening device). The company also offers HearALL for additional diagnostics and TechALL, a virtual reality platform for remote ophthalmic technician support. All products integrate seamlessly with existing office IT infrastructure and support both in-office and at-home evaluations for conditions including glaucoma and age-related macular degeneration.